US0231351067 - Common Stock - After market: 102.1 -0.14 (-0.14%)
Date | Firm | Action | Rating |
---|---|---|---|
2023-01-25 | UBS | Maintains | Buy |
2023-01-24 | Telsey Advisory Group | Maintains | Outperform |
2023-01-13 | Goldman Sachs | Maintains | Buy |
2023-01-11 | Cowen & Co. | Maintains | Outperform |
2023-01-04 | New Street Research | Initiate | Buy |
2022-12-19 | Evercore ISI Group | Maintains | Outperform |
2022-12-16 | JP Morgan | Maintains | Overweight |
2022-12-01 | Cowen & Co. | Maintains | Outperform |
2022-11-22 | Piper Sandler | Maintains | Overweight |
2022-11-15 | MoffettNathanson | Initiate | Outperform |
2022-11-14 | Rosenblatt | Maintains | Neutral |
2022-11-02 | Tigress Financial | Maintains | Buy |
2022-10-28 | Mizuho | Maintains | Buy |
2022-10-28 | DA Davidson | Maintains | Buy |
2022-10-28 | JMP Securities | Maintains | Market Outperform |
2022-10-28 | Deutsche Bank | Maintains | Buy |
2022-10-28 | Needham | Maintains | Buy |
2022-10-28 | Oppenheimer | Maintains | Outperform |
2022-10-28 | RBC Capital | Maintains | Outperform |
2022-10-28 | Barclays | Maintains | Overweight |
2022-10-28 | Cowen & Co. | Maintains | Outperform |
2022-10-28 | Telsey Advisory Group | Maintains | Outperform |
2022-10-28 | Wedbush | Maintains | Outperform |
2022-10-28 | Wells Fargo | Maintains | Overweight |
2022-10-28 | Raymond James | Maintains | Outperform |
2022-10-28 | Truist Securities | Maintains | Buy |
2022-10-28 | JP Morgan | Maintains | Overweight |
2022-10-28 | Baird | Maintains | Outperform |
2022-10-28 | Credit Suisse | Maintains | Outperform |
2022-10-28 | B of A Securities | Maintains | Buy |
Find the competitors with the best analyst ratings on the USA